2020
DOI: 10.1101/2020.10.20.347328
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

High-throughput transcriptomics and benchmark concentration modeling for potency ranking of per- and polyfluoroalkyl substances (PFAS) in exposed human liver cell spheroids

Abstract: Per- and polyfluoroalkyl substances (PFAS) are some of the most prominent organic contaminants in human blood. Although the toxicological implications from human exposure to perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) are well established, data on lesser-understood PFAS are limited. New approach methodologies (NAMs) that apply bioinformatic tools to high-throughput data are being increasingly considered to inform risk assessment for data-poor chemicals. The aim of this investigation was to i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 58 publications
0
3
0
Order By: Relevance
“… 27 , 139 Wishing to have a better understanding of the risk associated with cumulative exposure to PFAS, we encourage researchers to focus on identifying the unknown fraction of PFAS in human blood and to subsequently investigate the toxicokinetics and toxicity of these substances. This investigation could be done by performing in vivo animal experiments, but researchers may also employ other sources, such as in vitro studies and accompanying quantitative in vitro to in vivo extrapolation (QIVIVE) methods, 140 , 141 or human epidemiological studies. Such data would allow researchers to extend the number of internal RPFs and to verify the animal toxicity data-derived RPFs with alternative resources.…”
Section: Discussionmentioning
confidence: 99%
“… 27 , 139 Wishing to have a better understanding of the risk associated with cumulative exposure to PFAS, we encourage researchers to focus on identifying the unknown fraction of PFAS in human blood and to subsequently investigate the toxicokinetics and toxicity of these substances. This investigation could be done by performing in vivo animal experiments, but researchers may also employ other sources, such as in vitro studies and accompanying quantitative in vitro to in vivo extrapolation (QIVIVE) methods, 140 , 141 or human epidemiological studies. Such data would allow researchers to extend the number of internal RPFs and to verify the animal toxicity data-derived RPFs with alternative resources.…”
Section: Discussionmentioning
confidence: 99%
“…For practical application of the RPF method for PFAS, we furthermore stimulate scientific debate to work towards agreement of RPFs for PFAS. Several efforts have been made since 2018 on deriving RPFs for PFAS, such as RPFs based on cytotoxicity and intracellular reactive oxygen species formation in human HepG2 cells in vitro (Amstutz et al, 2022), based on gene expression in human HepaRG cells (Louisse et al in preparation) and in human liver spheroids in vitro (Reardon et al, 2020); based on thyroid hormone disruption potential in vitro (Behnisch et al, 2021); and based on several systemic toxicity effects in vivo (Goodrum et al, 2021;Bil et al 2022b;Rietjens et al, 2021;Zeilmaker et al, 2018). The RPF analyses performed in these publications do not necessarily adhere to the same methodological approaches and criteria, for instance on ensuring parallel curve fitting (Bil et al 2022b).…”
Section: Discussionmentioning
confidence: 99%
“…The use of well‐characterized cell lines offers a wide array of possibilities for manipulating experimental variables to obtain a multitude of endpoints in a timely manner. The utility of screening methods employing HTS methods has already been demonstrated for PFAS chemicals (Reardon et al, 2020; Rowan‐Carroll et al, 2021; Singh & Hsieh, 2021). While not inclusive of all assays, endpoints, and cell types, Table 2 provides some examples of approaches that can be and are being used for assessing the human health effects of short‐chain PFAS.…”
Section: Advantages and Limitations Of In Vitro Methodsmentioning
confidence: 99%